Ava Scatoni

No ORCID on file · 9 papers in corpus · active 2024-2026

Study types

  • article 7
  • other 2

Condition tags

  • endometriosis 9
  • dysmenorrhea 3
article 2026
91. Anogenital distance as a biomarker for endometriosis in adolescents: a case-control study
·doi:10.1016/j.jpag.2026.01.136
article 2026
98. Emergency Department Utilization among Adolescents with Endometriosis
·doi:10.1016/j.jpag.2026.01.143
article 2026
9. Incidence of laparoscopically-confirmed endometriosis diagnosis among adolescent and young adults with a clinical diagnosis of endometriosis – a rethinking of the classical patient paradigm
·doi:10.1016/j.jpag.2026.01.034
other 2026
Efficacy and Tolerability of Elagolix in Adolescents and Young Adults with Endometriosis: A Small, Single-Center Retrospective Cohort Study
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2026.02.008

STUDY OBJECTIVE: To evaluate the efficacy and tolerability of the gonadotropin-releasing hormone antagonist elagolix for endometriosis-associated pain symptoms in adolescents and young adults (AYAs) METHODS: We performed a retrospective coh…

article 2025
Surgical management of endometriosis in adolescents versus adults: a National Surgical Quality Improvement Program study
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.07.020
article 2025
Use of the Drospirenone-Only Contraceptive Pill in Adolescents With Endometriosis
·doi:10.1097/ogx.0000000000001408

(Abstracted from J Pediatr Adolesc Gynecol 2024;37(4):402–406 One of the leading causes of dysmenorrhea in adolescents is endometriosis, or the growth of endometrial tissue outside the uterus. Endometriosis significantly impacts quality of …

article 2024
COMPARING SURGICAL CARE OF ENDOMETRIOSIS IN ADOLESCENCE VERSUS ADULTHOOD
·doi:10.1016/j.fertnstert.2024.07.582
other 2024
Danazol's use for menstrual suppression in transgender individuals: A retrospective multi-site cohort study
Women's health (London, England) ·doi:10.1177/17455057241265081

BACKGROUND: Danazol is a synthetic progestin with androgenic effects that is approved by the Food and Drug Administration for treatment of endometriosis, benign fibrocystic breast disease, and hereditary angioedema. In recent years, increas…

article 2024
Use of the Drospirenone-Only Contraceptive Pill in Adolescents with Endometriosis
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2024.02.003

STUDY OBJECTIVE: To evaluate the efficacy and tolerability of a progestin-only pill containing 4 mg drospirenone (DRSP) as a hormonal therapy for the management of endometriosis-associated symptoms in adolescents and young adults. DESIGN: …